Key facts
- This page summarizes Rene Russo's Form 4 filing for Adagio Therapeutics, Inc. (IVVD).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 09 Aug 2021, 19:55.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
One third (1/3) of the option shall vest on August 5, 2022, and thereafter, the remainder of the option shall vest in 24 equal monthly installments on the 5th day of each month, subject to the Reporting Person's continuous service on each vesting date.